Differential DJ-1 gene expression in Parkinson's disease

Neurobiology of Disease

Volumn 36, Issue 2, 2009, Pages 393-400

  Kumaran, Ravindran ^a   Vandrovcova, Jana ^a   Luk, Connie ^a   Sharma, Simone ^b,c   Renton, Alan ^b,c   Wood, Nicholas W ^b   Hardy, John A ^a,b   Lees, Andrew J ^a   Bandopadhyay, Rina ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

DJ 1 mRNA; Parkinson's disease; Post mortem human brain; Quantitative real time PCR

Indexed keywords

DJ 1 PROTEIN; LEVODOPA; MESSENGER RNA;

ADULT; AGED; AMYGDALOID NUCLEUS; ARTICLE; AUTOPSY; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; ENTORHINAL CORTEX; FEMALE; FRONTAL CORTEX; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; MEDULLA OBLONGATA; PARIETAL LOBE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; PUTAMEN; UPREGULATION;

AGED; AGED, 80 AND OVER; AMYGDALA; CEREBELLUM; ENTORHINAL CORTEX; FEMALE; FRONTAL LOBE; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; ONCOGENE PROTEINS; PARIETAL LOBE; PARKINSON DISEASE; PUTAMEN; RNA, MESSENGER; UP-REGULATION;

EID: 70349784928     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.08.011     Document Type: Article

References (61)

1. Abou-Sleiman P.M., Healy D.G., Quinn N., Lees A.J., and Wood N.W. The role of pathogenic DJ-1 mutations in Parkinson's disease. Ann. Neurol. 54 (2003) 283-286
2. Bandopadhyay R., Kingsbury A.E., Cookson M.R., Reid A.R., Evans I.M., Hope A.D., Pittman A.M., Lashley T., Canet-Aviles R., Miller D.W., McLendon C., Strand C., Leonard A.J., Abou-Sleiman P.M., Healy D.G., Ariga H., Wood N.W., de Silva R., Revesz T., Hardy J.A., and Lees A.J. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain 127 (2004) 420-430
3. Bandopadhyay R., Miller D.W., Kingsbury A.E., Jowett T.P., Kaleem M.M., Pittman A.M., de Silva R., Cookson M.R., and Lees A.J. Development, characterisation and epitope mapping of novel monoclonal antibodies for DJ-1 (PARK7) protein. Neurosci. Lett 383 (2005) 225-230
4. Bandyopadhyay S., and Cookson M.R. Evolutionary and functional relationships within the DJ1 superfamily. BMC Evol. Biol. 4 (2004) 6
5. Baulac S., Lu H., Strahle J., Yang T., Goldberg M.S., Shen J., Schlossmacher M.G., Lemere C.A., Lu Q., and Xia W. Increased DJ-1 expression under oxidative stress and in Alzheimer's disease brains. Mol. Neurodegener. 4 (2009) 12
6. Beyer K., Domingo-Sabat M., Humbert J., Carrato C., Ferrer I., and Ariza A. Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease. Neurogenetics 9 (2008) 163-172
7. Blackinton J., Kumaran R., van der Brug M.P., Ahmad R., Olson L., Galter D., Lees A., Bandopadhyay R., and Cookson M.R. Post-transcriptional regulation of mRNA associated with DJ-1 in sporadic Parkinson disease. Neurosci. Lett. 452 (2009) 8-11
8. Bonifati V., Rizzu P., van Baren M.J., Schaap O., Breedveld G.J., Krieger E., Dekker M.C., Squitieri F., Ibanez P., Joosse M., van Dongen J.W., Vanacore N., van Swieten J.C., Brice A., Meco G., van Duijn C.M., Oostra B.A., and Heutink P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299 (2003) 256-259
9. Bossers K., Meerhoff G., Balesar R., van Dongen J.W., Kruse C.G., Swaab D.F., and Verhaagen J. Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death. Brain Pathol. 19 (2009) 91-107
10. Braak H., Del Tredici K., Bratzke H., Hamm-Clement J., Sandmann-Keil D., and Rub U. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J. Neurol. 249 Suppl. 3 (2002) III/1-5
11. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., and Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24 (2003) 197-211
12. Campbell B.C., Li Q.X., Culvenor J.G., Jakala P., Cappai R., Beyreuther K., Masters C.L., and McLean C.A. Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies. Neurobiol. Dis. 7 (2000) 192-200
13. Canet-Aviles R.M., Wilson M.A., Miller D.W., Ahmad R., McLendon C., Bandyopadhyay S., Baptista M.J., Ringe D., Petsko G.A., and Cookson M.R. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 9103-9108
14. Choi J., Sullards M.C., Olzmann J.A., Rees H.D., Weintraub S.T., Bostwick D.E., Gearing M., Levey A.I., Chin L.S., and Li L. Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J. Biol. Chem. 281 (2006) 10816-10824
15. Coulson D.T., Brockbank S., Quinn J.G., Murphy S., Ravid R., Irvine G.B., and Johnston J.A. Identification of valid reference genes for the normalization of RT qPCR gene expression data in human brain tissue. BMC Mol. Biol. 9 (2008) 46
16. Davidson B., Hadar R., Schlossberg A., Sternlicht T., Slipicevic A., Skrede M., Risberg B., Florenes V.A., Kopolovic J., and Reich R. Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma. Hum. Pathol. 39 (2008) 87-95
17. Di Fonzo A., Rohe C.F., Ferreira J., Chien H.F., Vacca L., Stocchi F., Guedes L., Fabrizio E., Manfredi M., Vanacore N., Goldwurm S., Breedveld G., Sampaio C., Meco G., Barbosa E., Oostra B.A., and Bonifati V. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 365 (2005) 412-415
18. Di Monte D.A. The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins. Lancet Neurol. 2 (2003) 531-538
19. Fuchs J., Tichopad A., Golub Y., Munz M., Schweitzer K.J., Wolf B., Berg D., Mueller J.C., and Gasser T. Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain. FASEB J. 22 (2008) 1327-1334
20. Galter D., Westerlund M., Belin A.C., and Olson L. DJ-1 and UCH-L1 gene activity patterns in the brains of controls, Parkinson and schizophrenia patients and in rodents. Physiol. Behav. 92 (2007) 46-53
21. Goldberg M.S., Pisani A., Haburcak M., Vortherms T.A., Kitada T., Costa C., Tong Y., Martella G., Tscherter A., Martins A., Bernardi G., Roth B.L., Pothos E.N., Calabresi P., and Shen J. Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 45 (2005) 489-496
22. Guatala R.V., and Reddy H. The use of real-time PCR analysis in a gene expression study of Alzheimer's disease post-mortem brains. J. Neurosci. Methods 132 (2003) 101-107
23. Hague S., Rogaeva E., Hernandez D., Gulick C., Singleton A., Hanson M., Johnson J., Weiser R., Gallardo M., Ravina B., Gwinn-Hardy K., Crawley A., St George-Hyslop P.H., Lang A.E., Heutink P., Bonifati V., Hardy J., and Singleton A. Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation. Ann. Neurol. 54 (2003) 271-274
24. Hod Y., Pentyala S.N., Whyard T.C., and El-Maghrabi M.R. Identification and characterization of a novel protein that regulates RNA-protein interaction. J. Cell. Biochem. 72 (1999) 435-444
25. Hurley M.J., Mash D.C., and Jenner P. Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR. Eur. J. Neurosci. 18 (2003) 2668-2672
26. Jellinger K.A. Neuropathology of dementia in Parkinson's disease. Ann. Neurol. 59 (2006) 727
27. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., and Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392 (1998) 605-608
28. Kotaria N., Hinz U., Zechel S., and von Bohlen Und Halbach O. Localization of DJ-1 protein in the murine brain. Cell Tissue Res. 322 (2005) 503-507
29. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., and Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18 (1998) 106-108
30. Kumaran R., Kingsbury A., Coulter I., Lashley T., Williams D., de Silva R., Mann D., Revesz T., Lees A., and Bandopadhyay R. DJ-1 (PARK7) is associated with 3R and 4R tau neuronal and glial inclusions in neurodegenerative disorders. Neurobiol. Dis. 28 (2007) 122-132
31. Lashley T., Holton J.L., Gray E., Kirkham K., O'Sullivan S.S., Hilbig A., Wood N.W., Lees A.J., and Revesz T. Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson's disease patients. Acta Neuropathol. 115 (2008) 417-425
32. Lee S.J., Kim S.J., Kim I.K., Ko J., Jeong C.S., Kim G.H., Park C., Kang S.O., Suh P.G., Lee H.S., and Cha S.S. Crystal structures of human DJ-1 and Escherichia coli Hsp31, which share an evolutionarily conserved domain. J. Biol. Chem. 278 (2003) 44552-44559
33. Lev N., Ickowicz D., Barhum Y., Lev S., Melamed E., and Offen D. DJ-1 protects against dopamine toxicity. J. Neural. Transm. 116 (2009) 151-160
34. Liu F., Nguyen J.L., Hulleman J.D., Li L., and Rochet J.C. Mechanisms of DJ-1 neuroprotection in a cellular model of Parkinson's disease. J. Neurochem. 105 (2008) 2435-2453
35. MacDonald V., and Halliday G.M. Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson's disease. Mov. Disord. 17 (2002) 1166-1173
36. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., Cummings J., Duda J.E., Lippa C., Perry E.K., Aarsland D., Arai H., Ballard C.G., Boeve B., Burn D.J., Costa D., Del Ser T., Dubois B., Galasko D., Gauthier S., Goetz C.G., Gomez-Tortosa E., Halliday G., Hansen L.A., Hardy J., Iwatsubo T., Kalaria R.N., Kaufer D., Kenny R.A., Korczyn A., Kosaka K., Lee V.M., Lees A., Litvan I., Londos E., Lopez O.L., Minoshima S., Mizuno Y., Molina J.A., Mukaetova-Ladinska E.B., Pasquier F., Perry R.H., Schulz J.B., Trojanowski J.Q., and Yamada M. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65 (2005) 1863-1872
37. Meulener M.C., Xu K., Thomson L., Ischiropoulos H., and Bonini N.M. Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 12517-12522
38. Mitsumoto A., and Nakagawa Y. DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin. Free Radic. Res. 35 (2001) 885-893
39. Moore D.J., Zhang L., Troncoso J., Lee M.K., Hattori N., Mizuno Y., Dawson T.M., and Dawson V.L. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress. Hum. Mol. Genet. 14 (2005) 71-84
40. Nagakubo D., Taira T., Kitaura H., Ikeda M., Tamai K., Iguchi-Ariga S.M., and Ariga H. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem. Biophys. Res. Commun. 231 (1997) 509-513
41. Neumann M., Muller V., Gorner K., Kretzschmar H.A., Haass C., and Kahle P.J. Pathological properties of the Parkinson's disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease. Acta Neuropathol. 107 (2004) 489-496
42. Niki T., Takahashi-Niki K., Taira T., Iguchi-Ariga S.M., and Ariga H. DJBP: a novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex. Mol. Cancer Res. 1 (2003) 247-261
43. Olzmann J.A., Bordelon J.R., Muly E.C., Rees H.D., Levey A.I., Li L., and Chin L.S. Selective enrichment of DJ-1 protein in primate striatal neuronal processes: implications for Parkinson's disease. J. Comp. Neurol. 500 (2007) 585-599
44. Paisan-Ruiz C., Jain S., Evans E.W., Gilks W.P., Simon J., van der Brug M., Lopez de Munain A., Aparicio S., Gil A.M., Khan N., Johnson J., Martinez J.R., Nicholl D., Carrera I.M., Pena A.S., de Silva R., Lees A., Marti-Masso J.F., Perez-Tur J., Wood N.W., and Singleton A.B. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44 (2004) 595-600
45. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. e45 (2001) 29
46. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., and Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (1997) 2045-2047
47. Rascol O., Sabatini U., Fabre N., Brefel C., Loubinoux I., Celsis P., Senard J.M., Montastruc J.L., and Chollet F. The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients. Brain 120 Pt 1 (1997) 103-110
48. Rizzu P., Hinkle D.A., Zhukareva V., Bonifati V., Severijnen L.A., Martinez D., Ravid R., Kamphorst W., Eberwine J.H., Lee V.M., Trojanowski J.Q., and Heutink P. DJ-1 colocalizes with tau inclusions: a link between parkinsonism and dementia. Ann. Neurol. 55 (2004) 113-118
49. Shang H., Lang D., Jean-Marc B., and Kaelin-Lang A. Localization of DJ-1 mRNA in the mouse brain. Neurosci. Lett. 367 (2004) 273-277
50. Shendelman S., Jonason A., Martinat C., Leete T., and Abeliovich A. DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biol. e362 (2004) 2
51. Simunovic F., Yi M., Wang Y., Macey L., Brown L.T., Krichevsky A.M., Andersen S.L., Stephens R.M., Benes F.M., and Sonntag K.C. Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology. Brain 132 (2008) 1795-1805
52. Taira T., Saito Y., Niki T., Iguchi-Ariga S.M., Takahashi K., and Ariga H. DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 5 (2004) 213-218
53. Takahashi K., Taira T., Niki T., Seino C., Iguchi-Ariga S.M., and Ariga H. DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor. J. Biol. Chem. 276 (2001) 37556-37563
54. Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A.R., Healy D.G., Albanese A., Nussbaum R., Gonzalez-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W.P., Latchman D.S., Harvey R.J., Dallapiccola B., Auburger G., and Wood N.W. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304 (2004) 1158-1160
55. van der Brug M.P., Blackinton J., Chandran J., Hao L.Y., Lal A., Mazan-Mamczarz K., Martindale J., Xie C., Ahmad R., Thomas K.J., Beilina A., Gibbs J.R., Ding J., Myers A.J., Zhan M., Cai H., Bonini N.M., Gorospe M., and Cookson M.R. RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways. Proc. Natl. Acad. Sci. U. S. A 105 (2008) 10244-10249
56. Vilarino-Guell C., Soto A.I., Lincoln S.J., Ben Yahmed S., Kefi M., Heckman M.G., Hulihan M.M., Chai H., Diehl N.N., Amouri R., Rajput A., Mash D.C., Dickson D.W., Middleton L.T., Gibson R.A., Hentati F., and Farrer M.J. ATP13A2 variability in Parkinson disease. Hum. Mutat. 30 (2009) 406-410
57. Wagenfeld A., Gromoll J., and Cooper T.G. Molecular cloning and expression of rat contraception associated protein 1 (CAP1), a protein putatively involved in fertilization. Biochem. Biophys. Res. Commun. 251 (1998) 545-549
58. Westerlund M., Belin A.C., Anvret A., Hakansson A., Nissbrandt H., Lind C., Sydow O., Olson L., and Galter D. Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material. FASEB J. 22 (2008) 3509-3514
59. Wilson M.A., Collins J.L., Hod Y., Ringe D., and Petsko G.A. The 1.1-A resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 9256-9261
60. Yu H., Sternad D., Corcos D.M., and Vaillancourt D.E. Role of hyperactive cerebellum and motor cortex in Parkinson's disease. Neuroimage 35 (2007) 222-233
61. Zhou W., Zhu M., Wilson M.A., Petsko G.A., and Fink A.L. The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein. J. Mol. Biol. 356 (2006) 1036-1048